Lemmon Lab Members




                                                                                        Summary of Projects
Diego
Diego Alvarado
Postdoctoral Fellow
dalvarad@mail.med.upenn.edu
I aim to obtain a quantitative and mechanistic understanding of the Drosophila EGF receptor (DER) system through biophysical and biochemical approaches.  Together with a wealth of existing genetic information, these studies should generate a more complete picture of how the DER signaling complex functions in development and disease.  In particular, I am attempting to establish the binding affinities of all four DER ligands for the receptor, and determine how different DER domains contribute to ligand binding and dimerization.  In addition I will continue lab efforts to examine how the secreted antagonist Argos modulates DER signaling, possibly by sequestering multiple ligands and through interactions with heparan sulfate proteoglycans.
Kelley

Kelley A. Bethoney
Graduate Student
kbethone@mail.med.upenn.edu
I am interested in understanding the function of members of the large dynamin GTPase family, specifically dynamin, in membrane trafficking. Utilizing both cellular and biophysical approaches, I hope to better understand dynamin’s mechanism for participation in vesicle scission in clathrin-mediated endocytosis, specifically looking at the role of dynamin’s pleckstrin homology (PH) domain in this process. In addition, I am also pursuing crystallographic studies on members of the dynamin family to better understand the structural basis of dynamin function within the trafficking pathways.
sunghee
Sung Hee Choi
Graduate Student
sunghee@mail.med.upenn.edu
From recent clinical studies, several somatic mutations in the tyrosine kinase domain in EGFR were isolated from chemotherapy-reflecting, gefinitib-sensitive Non-Small Cell Lung Carcinomas (NSCLC) patients. I am interested in understanding how these mutations alter the function and regulation of the EGFR tyrosine kinase, as well as the cellular consequences of EGFR signaling.
Jessica

Jessica P. Dawson, Ph.D.

Postdoctoral Fellow
dawsonj@mail.med.upenn.edu
I am currently examining the energetic contribution of distinct regions of EGFR to receptor dimerization and ligand binding. A series of mutations were designed at specific contact points determined from the crystal structures and I am testing each mutant protein for dimerization (analytical ultracentrifugation), ligand binding (Biacore) and cellular signaling in vivo.
keleti

David Keleti

Graduate Student
dkeleti@mail.med.upenn.edu

An important component of signaling pathways is the recruitment of key proteins from the cytosol to a specific subcellular membrane where they can exert their function. This process is driven by small, phosphoinositide-binding modules within the “host” protein called the pleckstrin homology (PH) domains. Recent biochemical and biophysical analyses performed in our lab suggest that PH domains may fall into one of three functional categories based on their phosphoinositide binding: (1) a high affinity, high specificity class;  (2) a high affinity, reduced specificity class ; (3) a low affinity, promiscuous class in which lipid binding is probably too weak to account for an in vivo response.  I propose to study the latter two classes of PH domain using the following approaches:  examine the regiospecificity of PH domain binding to lipids, examine phosphoinositide binding to 66 representative human PH domains, find interacting protein partners of representative human PH domains.

Daryl

Daryl E. Klein

Graduate Student, MD/Ph.D.
dek@mail.med.upenn.edu
Personal web page
The EGF receptor and its cognate ligands are found overexpressed or over-activated in many cancers.  Highly selective antagonists of the EGFR, erbB2, and other erbB receptors, are extremely desirable for the treatment of a variety of cancers.  My research is focused on two natural inhibitors of the EGF receptor axis found in Drosophila melanogaster.  One (Argos) is a secreted protein with an EGF like module and resembles a growth factor, the other (Kekkon) is a leucine rich repeat (LRR) containing transmembrane protein. My research proposal focuses on obtaining a detailed mechanistic and structural understanding of how Argos and Kekkon function to antagonize dEGFR activation.
Lemmon

Mark A. Lemmon, Ph.D.
Associate Professor
mlemmon@mail.med.upenn.edu

For a description of the lab's research click here.
Jeannine

Jeannine M. Mendrola, Ph.D.
Postdoctoral Fellow
mendrola@yahoo.com

My current focus in the lab is to develop a protein complementation assay to assess homo- and hetero-dimerization of erbB receptors in a cellular context.  Systems utilizing EYFP and mDHFR are under development and the preliminary results are encouraging.  In concert with the biophysical/structural studies ongoing in the laboratory, we hope to parse out the discrete regions of these receptors that make specific contacts in receptor dimers induced by exposure to erbB ligands.

Kartik

Kartik Narayan Ph.D.

Postdoctoral Fellow
kartik@mail.med.upenn.edu

I am investigating  proteins and domains that might preferentially bind phosphatidylinositols-3,5-P2 using binding and crystallographic methods.


Pictures from Faseb Meeting

                                                                                        Former Lab Members

Mark Baumeister
New York University, Postdoctoral Fellow
Mitchell B. Berger
UPenn, MD/Ph.D. Program
Kate Ferguson University of Pennsylvania, Assistant Professor
Jennifer M. Kavran
Yale University, Ph.D. Program
Meghan King
Rockefeller University, Postdoctoral Fellow
Anthony Lee
UCLA, Postdoctoral Fellow
Valerie Nappi
VivaScience, New York
Mira M. Sachdeva
University of Pennsylvania, MD/Ph.D. Program
Vijay G. Sankaran
Harvard Medical School, MD/Ph.D. Program
Jong Yu
Princenton University, Postdoctoral Fellow


Lab Mailing Address:
Department of Biochemistry and Biophysics,
University of Pennsylvania, School of Medicine
242 Anatomy-Chemistry Building,
Philadelphia, PA 19104-6059

Telephone: (215) 898-3411
Fax: (215) 573-4764
Lab Address:
Department of Biochemistry and Biophysics,
University of Pennsylvania, School of Medicine
807 Stellar-Chance Building,
422 Curie Blvd,
Philadelphia, PA 19104-6059